Mapping of Carboxypeptidase M in Normal Human Kidney and Renal Cell Carcinoma: Expression in Tumor-Associated Neovasculature and Macrophages

Journal of Histochemistry and Cytochemistry

Volumn 61, Issue 3, 2013, Pages 218-235

  Denis, Catherine J ^a   Van Acker, Nathalie ^b   De Schepper, Stefanie ^b   De Bie, Martine ^b   Andries, Luc ^b   Fransen, Erik ^a   Hendriks, Dirk ^a   Kockx, Mark M ^b   Lambeir, Anne Marie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HistoGeneX NV   (Belgium)

Author keywords

angiogenesis; enzyme; epidermal growth factor; epidermal growth factor receptor; immunofluorescence; immunohistochemistry; pathology; renal cell carcinoma

Indexed keywords

CARBOXYPEPTIDASE; CARBOXYPEPTIDASE M; EPIDERMAL GROWTH FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BOWMAN CAPSULE; CANCER PATIENT; CAPILLARY; CARCINOGENESIS; CELL DEDIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GLOMERULAR MESANGIAL CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; KIDNEY BLOOD VESSEL; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; KIDNEY INTERSTITIUM; KIDNEY TUBULE; MESANGIUM CELL; NEPHRECTOMY; NEPHROBLASTOMA; PHAGOCYTOSIS; PODOCYTE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

ADULT; CARCINOMA, RENAL CELL; CARCINOMA, SQUAMOUS CELL; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; MACROPHAGES; METALLOENDOPEPTIDASES; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS;

EID: 84875510120     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/0022155412470456     Document Type: Article

References (42)

1. Andreesen R,Gadd S,Costabel U,Leser HG,Speth V,Cesnik B,Atkins RC.Human macrophage maturation and heterogeneity: restricted expression of late differentiation antigens in situ.Cell Tissue Res. 1988;253 (2): 271-279.
2. Bravo J,Quiroz Y,Pons H,Parra G,Herrera-Acosta J,Johnson RJ,Rodriguez-Iturbe B.Vimentin and heat shock protein expression are induced in the kidney by angiotensin and by nitric oxide inhibition.Kidney Int Suppl. 2003;86:S46-S51.
3. Cheville JC,Lohse CM,Zincke H,Weaver AL,Blute ML.Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.Am J Surg Pathol. 2003;27 (5): 612-624.
4. Ciardiello F,Tortora G.EGFR antagonists in cancer treatment.N Engl J Med. 2008;358 (11): 1160-1174.
5. Cohen D,Lane B,Jin T,Magi-Galluzzi C,Finke J,Rini BI,Bukowski RM,Zhou M.The prognostic significance of epidermal growth factor receptor expression in clear cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.Clin Genitourin Cancer. 2007;5 (4): 264-270.
6. Eble JNSauter GEpstein JISesterhenn IA, ed. Lyon, France: IARC Press; 2004:.
7. Ferlay J,Parkin DM,Steliarova-Foucher E.Estimates of cancer incidence and mortality in Europe in 2008.Eur J Cancer. 2010;46 (4): 765-781.
8. GentlemanRIhakaR. 2002. R, version 2.13. Vienna, Austria: The R Foundation for Statistical Computing. www.r-project.org. Accessed January 5, 2012.
9. Goel S,Hidalgo M,Perez-Soler R.EGFR inhibitor-mediated apoptosis in solid tumors.J Exp Ther Oncol. 2007;6 (4): 305-320.
10. Hamai K,Ikeda R,Sumi H,Mihara H.Carboxypeptidase activity in human urine from healthy subjects and renal disease patients.Clin Chim Acta. 1990;188 (3): 233-241.
11. Jemal A,Siegel R,Ward E,Hao Y,Xu J,Thun MJ.Cancer statistics, 2009.CA Cancer J Clin. 2009;59 (4): 225-249.
12. Julow J,Szeifert GT,Balint K,Nyary I,Nemes Z.The role of microglia/macrophage system in the tissue response to I-125 interstitial brachytherapy of cerebral gliomas.Neurol Res. 2007a;29 (3): 233-238.
13. Julow J,Szeifert GT,Balint K,Nyary I,Nemes Z.Tissue response to iodine-125 interstitial brachytherapy of cerebral gliomas.Prog Neurol Surg. 2007b;20:312-323.
14. Kamath S,Buolamwini JK.Targeting EGFR and HER-2 receptor tyrosine kinases for cancer drug discovery and development.Med Res Rev. 2006;26 (5): 569-594.
15. Kovacs J,Varga A,Bessenyei M,Gomba S.Renal cell cancer associated with sarcoid-like reaction.Pathol Oncol Res. 2004;10 (3): 169-171.
16. Ljungberg B,Cowan NC,Hanbury DC,Hora M,Kuczyk MA,Merseburger AS,Patard JJ,Mulders PF,Sinescu IC.EAU guidelines on renal cell carcinoma: the 2010 update.Eur Urol. 2010;58 (3): 398-406.
17. Mantovani A,Allavena P,Sica A,Balkwill F.Cancer-related inflammation.Nature. 2008;454 (7203): 436-444.
18. McGwire GB,Becker RP,Skidgel RA.Carboxypeptidase M, a glycosylphosphatidylinositol-anchored protein, is localized on both the apical and basolateral domains of polarized Madin-Darby canine kidney cells.J Biol Chem. 1999;274 (44): 31632-31640.
19. McGwire GB,Skidgel RA.Extracellular conversion of epidermal growth factor (EGF) to des-Arg53-EGF by carboxypeptidase M.J Biol Chem. 1995;270 (29): 17154-17158.
20. Minner S,Rump D,Tennstedt P,Simon R,Burandt E,Terracciano L,Moch H,Wilczak W,Bokemeyer C,Fisch M, et al.Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.Cancer. 2012;118 (5): 1268-1275.
21. Moch H,Sauter G,Buchholz N,Gasser TC,Bubendorf L,Waldman FM,Mihatsch MJ.Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma.Hum Pathol. 1997;28 (11): 1255-1259.
22. Ohse T,Pippin JW,Chang AM,Krofft RD,Miner JH,Vaughan MR,Shankland SJ.The enigmatic parietal epithelial cell is finally getting noticed: a review.Kidney Int. 2009;76 (12): 1225-1238.
23. Ravaud A,de Clermont H,Pasticier G,Smith D,Vendrely V,Maire JP.Epithelial growth factor receptor (EGFR) pathway and renal cell carcinoma.Target Oncol. 2007;2 (2): 99-105.
24. Rink M,Chun FK,Robinson B,Sun M,Karakiewicz PI,Bensalah K,Fisch M,Scherr DS,Lee RK,Margulis V, et al.Tissue-based molecular markers for renal cell carcinoma.Minerva Urol Nefrol. 2011;63 (4): 293-308.
25. Royer C,Lu X.Epithelial cell polarity: a major gatekeeper against cancer?r.Cell Death Differ. 2011;18 (9): 1470-1477.
26. Sauter G,Haley J,Chew K,Kerschmann R,Moore D,Carroll P,Moch H,Gudat F,Mihatsch MJ,Waldman F.Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer.Int J Cancer. 1994;57 (4): 508-514.
27. Schlondorff D,Banas B.The mesangial cell revisited: no cell is an island.J Am Soc Nephrol. 2009;20 (6): 1179-1187.
28. Sibilia M,Kroismayr R,Lichtenberger BM,Natarajan A,Hecking M,Holcmann M.The epidermal growth factor receptor: from development to tumorigenesis.Differentiation. 2007;75 (9): 770-787.
29. Sica A,Allavena P,Mantovani A.Cancer-related inflammation: the macrophage connection.Cancer Lett. 2008;267 (2): 204-215.
30. Skidgel RA,Davis RM,Erdos EG.Purification of a human urinary carboxypeptidase (kininase) distinct from carboxypeptidases A, B, or N.Anal Biochem. 1984;140 (2): 520-531.
31. Skidgel RA,Davis RM,Tan F.Human carboxypeptidase M: purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones.J Biol Chem. 1989;264 (4): 2236-2241.
32. Skidgel RA,Johnson AR,Erdos EG.Hydrolysis of opioid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes.Biochem Pharmacol. 1984;33 (21): 3471-3478.
33. Stec R,Grala B,Maczewski M,Bodnar L,Szczylik C.Chromophobe renal cell cancer: review of the literature and potential methods of treating metastatic disease.J Exp Clin Cancer Res. 2009;28:134.
34. Tamaskar I,Dhillon J,Pili R.Resistance to angiogenesis inhibitors in renal cell carcinoma.Clin Adv Hematol Oncol. 2011;9 (2): 101-110.
35. Toi M,Nakamura T,Mukaida H,Wada T,Osaki A,Yamada H,Toge T,Niimoto M,Hattori T.Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer.Cancer. 1990;65 (9): 1980-1984.
36. Tsakiris I,Soos G,Nemes Z,Kiss SS,Andras C,Szanto J,Dezso B.The presence of carboxypeptidase M in tumour cells signifies epidermal growth factor receptor expression in lung adenocarcinomas: the coexistence predicts a poor prognosis regardless of EGFR levels.J Cancer Res Clin Oncol. 2008;134 (4): 439-451.
37. Tsakiris I,Torocsik D,Gyongyosi A,Dozsa A,Szatmari I,Szanto A,Soos G,Nemes Z,Igali L,Marton I, et al.Carboxypeptidase M is regulated by lipids and CSFs in macrophages and dendritic cells and expressed selectively in tissue granulomas and foam cells.Lab Invest. 2012;92 (3): 345-361.
38. Valera VA,Merino MJ.Misdiagnosis of clear cell renal cell carcinoma.Nat Rev Urol. 2011;8 (6): 321-333.
39. Ward JM,Stevens JL,Konishi N,Kurata Y,Uno H,Diwan BA,Ohmori T.Vimentin metaplasia in renal cortical tubules of preneoplastic, neoplastic, aging, and regenerative lesions of rats and humans.Am J Pathol. 1992;141 (4): 955-964.
40. Weber K,Doucet M,Kominsky S.Renal cell carcinoma bone metastasis: elucidating the molecular targets.Cancer Metastasis Rev. 2007;26 (3-4): 691-704.
41. Yoshida K,Tosaka A,Takeuchi S,Kobayashi N.Epidermal growth factor receptor content in human renal cell carcinomas.Cancer. 1994;73 (7): 1913-1918.
42. Zeng F,Singh AB,Harris RC.The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.Exp Cell Res. 2009;315 (4): 602-610.